Advertisement
Singapore markets open in 4 hours 26 minutes
  • Straits Times Index

    3,287.75
    -5.38 (-0.16%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • Dow

    38,085.80
    -375.12 (-0.98%)
     
  • Nasdaq

    15,611.76
    -100.99 (-0.64%)
     
  • Bitcoin USD

    64,737.80
    +785.17 (+1.23%)
     
  • CMC Crypto 200

    1,394.13
    +11.56 (+0.84%)
     
  • FTSE 100

    8,078.86
    +38.48 (+0.48%)
     
  • Gold

    2,344.20
    +5.80 (+0.25%)
     
  • Crude Oil

    83.79
    +0.98 (+1.18%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • FTSE Bursa Malaysia

    1,569.25
    -2.23 (-0.14%)
     
  • Jakarta Composite Index

    7,155.29
    -7,174.53 (-50.07%)
     
  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

After a 50% Gain, Is It Too Late to Buy Biogen?

After a 50% Gain, Is It Too Late to Buy Biogen?

Biogen (NASDAQ: BIIB) investors cheered earlier this week after the biotech company scored a major regulatory victory. The U.S. Food and Drug Administration approved its controversial Alzheimer's drug. Now, some investors are wondering whether it's too late to get in on the Biogen story.